We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
-0.06%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$60.5B
AUM Growth
+$2.39B
(+4.1%)
Cap. Flow
+$1.77B
Cap. Flow
% of AUM
2.93%
Top 10 Holdings %
Top 10 Hldgs %
17.56%
Holding
4,827
New
882
Increased
1,455
Reduced
1,567
Closed
849
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.29B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$673M |
| 3 |
VanEck Semiconductor ETF
SMH
|
+$170M |
| 4 |
Oracle
ORCL
|
+$168M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$154M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$210M |
| 2 |
UnitedHealth
UNH
|
+$158M |
| 3 |
Netflix
NFLX
|
+$140M |
| 4 |
Dollar General
DG
|
+$135M |
| 5 |
Micron Technology
MU
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.07% |
| 2 | Consumer Discretionary | 6.01% |
| 3 | Healthcare | 4.63% |
| 4 | Industrials | 4.29% |
| 5 | Financials | 4.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3701
Riskified
RSKD
$672M
| $163K | ﹤0.01% |
+25,553
| New | +$145K |
|
|
TBI
3702
Trueblue
TBI
$234M
| $163K | ﹤0.01% |
15,852
-8,733
| -36% | -$94.6K |
|
3703
McEwen Inc
MUX
$1.03B
| $162K | ﹤0.01% |
17,616
-524
| -3% | -$5.76K |
|
3704
CALL
Teladoc Health
TDOC
$1.58B
| $161K | ﹤0.01% |
+16,500
| New | +$201K |
|
|
3705
PUT
Teladoc Health
TDOC
$1.58B
| $161K | ﹤0.01% |
+16,500
| New | +$201K |
|
3706
SkyWater Technology
SKYT
$1.51B
| $161K | ﹤0.01% |
+21,081
| New | +$183K |
|
3707
Protalix BioTherapeutics
PLX
$191M
| $161K | ﹤0.01% |
137,764
+119,949
| +673% | +$142K |
|
3708
Veru
VERU
$36.1M
| $161K | ﹤0.01% |
+19,152
| New | +$222K |
|
3709
Vuzix
VUZI
$190M
| $161K | ﹤0.01% |
119,218
+100,632
| +541% | +$139K |
|
3710
Clover Health Investments
CLOV
$2.28B
| $160K | ﹤0.01% |
130,352
+13,329
| +11% | +$12K |
|
3711
Escalade
ESCA
$257M
| $160K | ﹤0.01% |
11,569
-1,405
| -11% | -$18.8K |
|
|
VTNR
3712
DELISTED
Vertex Energy, Inc
VTNR
| $158K | ﹤0.01% |
+167,551
| New | +$197K |
|
3713
dLocal
DLO
$4.26B
| $157K | ﹤0.01% |
+19,442
| New | +$228K |
|
3714
PUT
Herbalife
HLF
$1.23B
| $156K | ﹤0.01% |
+15,000
| New | +$150K |
|
|
AKYA
3715
DELISTED
Akoya BioSciences
AKYA
| $154K | ﹤0.01% |
65,949
-72,329
| -52% | -$231K |
|
3716
CALL
Lightspeed Commerce
LSPD
$1.3B
| $153K | ﹤0.01% |
11,200
| – | – |
|
3717
Fulcrum Therapeutics
FULC
$248M
| $152K | ﹤0.01% |
24,517
-30,043
| -55% | -$228K |
|
3718
Bioventus
BVS
$799M
| $150K | ﹤0.01% |
26,171
+3,170
| +14% | +$17.4K |
|
3719
ProFrac Holding
ACDC
$771M
| $150K | ﹤0.01% |
+20,297
| New | +$168K |
|
3720
Beyond Meat
BYND
$288M
| $150K | ﹤0.01% |
+22,304
| New | +$158K |
|
3721
Plug Power
PLUG
$2.92B
| $149K | ﹤0.01% |
64,143
-454,093
| -88% | -$1.3M |
|
|
KYNB
3722
Kyntra Bio
KYNB
$28.5M
| $145K | ﹤0.01% |
+6,517
| New | +$201K |
|
3723
MarketWise
MKTW
$53.1M
| $145K | ﹤0.01% |
6,259
+5,665
| +954% | +$167K |
|
3724
PUT
Annovis Bio
ANVS
$70.6M
| $144K | ﹤0.01% |
25,000
| – | – |
|
3725
Compugen
CGEN
$216M
| $144K | ﹤0.01% |
85,693
+16,253
| +23% | +$33.9K |
|
Similar funds
Squarepoint's Q2 2024 Portfolio in Review
As of Q2 2024, Squarepoint held 4,827 positions worth $60.5B, up 4.1% from $58.1B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Squarepoint's Q2 2024 filing shows 882 new, 1,455 increased, 1,567 reduced and 849 closed positions. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 1,286,013 shares worth $700M. The largest sale was Apple, an estimated $210M.
By sector, the portfolio is most concentrated in Technology at 9.1% of assets, up from 8.5% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Squarepoint's largest Q2 2024 buy was State Street SPDR S&P 500 ETF Trust: 1,286,013 shares worth $700M.
- Squarepoint added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $1.29B increase.
- Squarepoint's biggest Q2 2024 reduction was Apple, cutting an estimated $210M.
- Squarepoint fully exited DraftKings in Q2 2024, selling an estimated $94.6M.
- Squarepoint's ten largest holdings make up 18% of its $60.5B portfolio in Q2 2024.
- Squarepoint opened 882 new positions and closed 849 in Q2 2024.
- Squarepoint's portfolio value rose 4.1% quarter-over-quarter to $60.5B.
Based on Squarepoint's 13F filing for Q2 2024, filed 14 Aug 2024.